As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Medtronic: Wolverine Trading LLC, Squarepoint Ops LLC, Sig Brokerage LP, Royal Bank of Canada, Point72 Asset Management L.P., Maven Securities LTD, Millennium Management LLC, LMR Partners LLP, Group One Trading LLC, Eisler Capital Management Ltd., D. E. Shaw & Co. Inc., Cubist Systematic Strategies LLC, Cetera Investment Advisers, Capstone Investment Advisors LLC, Citadel Advisors LLC, Balyasny Asset Management L.P., Bank of America Corp DE, BNP Paribas Financial Markets, Jane Street Group LLC, Tudor Investment Corp ET AL, Parallax Volatility Advisers L.P., Two Sigma Securities LLC, Credit Industriel ET Commercial, Susquehanna International Group LLP, Hsbc Holdings PLC, Concourse Financial Group Securities Inc., PEAK6 LLC, Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, Capital Fund Management S.A., Capula Management Ltd, Wells Fargo & Company MN, National Bank of Canada FI, Pura Vida Investments LLC, JPMorgan Chase & Co., Simplex Trading LLC, HighTower Advisors LLC, NINE MASTS CAPITAL Ltd, Garda Capital Partners LP, Allianz Asset Management GmbH, Wolverine Asset Management LLC, IMC Chicago LLC, and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.